期刊文献+

CD36基因多态性与急性冠脉综合征关联性的研究 被引量:10

Association between the single nucleotide polymorphisms of human CD36 gene and acute coronary syndrome
原文传递
导出
摘要 目的探讨新疆地区汉族、维吾尔(维)族人群CD36基因多态性与急性冠脉综合征(ACS)的关联性。方法采用聚合酶链反应一限制性片段长度多态性(PCR.RFLP)方法,对522例ACS患者和1215名健康体检者CD36基因单核苷酸多态性(sNP)进行基因型鉴定。结果在汉族和维族人群中,ACS组和对照组rsl722505的基因型及等位基因分布差异均有统计学意义(P值均〈0.05)。在汉族人群ACS组中rs17154181的A等位基因频率明显低于对照组(P=0.034)。logistic回归分析在调整混杂因素后,在汉族和维族人群中rsl722505的AA+AG基因型者患ACS风险明显高于GG基因型者,汉族(OR=1.436,95%CI:1.047—1.970,P=0.025),维族(OR=1.589,95%CI:1.009~2.473,P=0.046)。汉族人群rsl7154181的AA+AG基因型者患ACS风险明显低于GG基因型者(OR=0.667,95%CI:0.494—0.900,P=0.008)。结论CD36基因多态性在新疆地区汉族和维族人群间存在差异,且CD36基因可能与两族人群ACS的发生相关,rsl722505的AA+AG基因型可能是汉族和维族人群ACS的危险因素,rsl8154181的AA+AG基因型可能是汉族人群ACS的保护因素。 Objective The aim of the present study was to assess the association between the polymorphisms of CD36 gene and acute coronary syndrome (ACS). Methods Genotypes of CD36 single nucleotide polymorphisms were detected under PCR-RFLP in 522 patients with ACS and 1 215 controls. Results For people under Han and Uygur ethnicities, the distribution of genotypes and allele of rs 1722505 was significantly different between ACS and the controls (all P〈 0.05). For Han population, the frequency of A allele of rs17154181 was significantly lower in ACS group than that in the control group (P=0.034). Results from logistic regression analysis showed that the AA + AG genotype of rs 1722505 was significantly higher in ACS patients than that in controls both between the Hans and the Uygnrs (OR= 1.436,95%CI: 1.047-1.970, P=0.025 ; OR= 1.589,95%CI: 1.009-2.473, P=0.046, respectively). For Hart people, AA+ AG genotype of rs17154181 was significantly lower in ACS patients than that in controls (OR=0.667, 95% CI: 0.494-0.900, P=0.008). Conclusion Data from the present study suggested that the CD36 gene might serve as a genetic marker of ACS in both Hart and Uygnr populations.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2014年第2期200-204,共5页 Chinese Journal of Epidemiology
基金 新疆维吾尔自治区科技支撑计划(201233138)
关键词 急性冠脉综合征 CD36基因 单核苷酸多态性 Acute coronary syndrome CD36 gene Single nucleotide polymorphism
  • 相关文献

参考文献17

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2155
  • 2Febbraio M,Podrez EA,Smith JD. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice[J].{H}Journal of Clinical Investigation,2000,(8):1049-1056.
  • 3Podrez EA,Poliakov E,Shen Z. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions[J].{H}Journal of Biological Chemistry,2002,(41):38517-38523.
  • 4Huszar D,Varban ML,Rinninger F. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1[J].{H}Arteriosclerosis Thrombosis and Vasoular Biology,2000,(4):1068-1073.
  • 5Nozaki S,Tanaka T,Yamashita S. CD36 mediates longchain fatty acid transport in human myocardium:complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency[J].{H}Molecular and Cellular Biochemistry,1999,(1/2):129-135.
  • 6Braunwald E,Antman EM,Beasley JW. ACC/AHA 2002guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)[J].JAm Coil Cardiol,2002,(7):1366-1374.
  • 7Macfarlane PW,Browne D,Devine B. Modification of ACC/ESC criteria for acute myocardial infarction[J].{H}Journal of electrocardiology,2004,(Suppl):S98-103.
  • 8Nergiz-Unal R,Rademakers T,Cosemans JM. CD36 as a multiple-ligand signaling receptor in atherothrombosis[J].Cardiovasc Hematol Agents Med Chem,2011,(1):42-55.
  • 9Silverstein RL,Febbraio M. Febbraio,CD36,a scavenger receptor involved in immunity,metabolism,angiogenesis,and behavior[J].Sci Signal,2009,(72):re3.
  • 10Yamada Y,Doi T,Hamakubo T. Scavenger receptor family proteins:roles for atherosclerosis,host defence and disorders of the central nervous system[J].{H}Cellular and Molecular Life Sciences,1998,(7):628-640.

二级参考文献26

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2158

同被引文献149

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部